Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| ALKS | Reed Joshua | SVP, Chief Financial Officer | 10/08/2026 | Steuer-Abgabe | 40.11 | 4,069 | 163,208 | Form 4 |
| ALKS | Reed Joshua | SVP, Chief Financial Officer | 10/08/2026 | Optionsausübung | — | 9,164 | — | Form 4 |
| ALKT | Alvarez Maria Ines | Director | 10/05/2026 | Zuteilung | — | 630 | — | Form 4 |
| ALKT | Mitchell Steven R | Director | 10/05/2026 | Zuteilung | — | 490 | — | Form 4 |
| ALKT | Linville Judson C | Director | 10/05/2026 | Zuteilung | — | 420 | — | Form 4 |
| ALKT | Fox Jeffrey H | Director | 10/05/2026 | Zuteilung | — | 420 | — | Form 4 |
| ALKT | Smith Brian R | Director | 10/05/2026 | Zuteilung | — | 1,085 | — | Form 4 |
| ALKS | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 10/02/2026 | Verkauf | 41.03 | 2,034 | 83,455 | Form 4 |
| ALK | Birkett Rakow Diana | EVP & CEO of Hawaiian Airlines | 09/29/2026 | Steuer-Abgabe | 39.30 | 148 | 5,816 | Form 4 |
| ALK | Birkett Rakow Diana | EVP & CEO of Hawaiian Airlines | 09/29/2026 | Optionsausübung | — | 313 | — | Form 4 |
| ALK | Levine Kyle B | EVP Corp Pub Aff & Chf Leg Off | 09/29/2026 | Steuer-Abgabe | 39.93 | 83 | 3,314 | Form 4 |
| ALK | Levine Kyle B | EVP Corp Pub Aff & Chf Leg Off | 09/29/2026 | Optionsausübung | — | 210 | — | Form 4 |
| ALK | Berry Jason M | EVP & Chief Operating Officer | 09/23/2026 | Steuer-Abgabe | 39.70 | 792 | 31,442 | Form 4 |
| ALK | Berry Jason M | EVP & Chief Operating Officer | 09/23/2026 | Optionsausübung | — | 2,010 | — | Form 4 |
| ALK | Schneider Andrea L | Pres & CEO Horizon Airlines | 09/22/2026 | Steuer-Abgabe | 41.91 | 499 | 20,913 | Form 4 |
| ALK | Schneider Andrea L | Pres & CEO Horizon Airlines | 09/22/2026 | Optionsausübung | — | 499 | — | Form 4 |
| ALK | Schneider Andrea L | Pres & CEO Horizon Airlines | 09/22/2026 | Steuer-Abgabe | 41.91 | 48 | 2,012 | Form 4 |
| ALK | Schneider Andrea L | Pres & CEO Horizon Airlines | 09/22/2026 | Optionsausübung | — | 48 | — | Form 4 |
| ALK | Harrison Andrew R | EVP AND CCO | 09/22/2026 | Steuer-Abgabe | 41.91 | 869 | 36,420 | Form 4 |
| ALK | Harrison Andrew R | EVP AND CCO | 09/22/2026 | Optionsausübung | — | 869 | — | Form 4 |
| ALK | Minicucci Benito | CEO AND PRESIDENT | 09/22/2026 | Steuer-Abgabe | 49.91 | 2,698 | 134,657 | Form 4 |
| ALK | Minicucci Benito | CEO AND PRESIDENT | 09/22/2026 | Optionsausübung | — | 2,698 | — | Form 4 |
| ALKT | Shootman Alex | Chief Executive Officer | 09/08/2026 | Steuer-Abgabe | 19.38 | 16,188 | 313,723 | Form 4 |
| ALKS | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 09/03/2026 | Verkauf | 48.01 | 2,034 | 97,652 | Form 4 |
| ALKT | Sachdeva Prerna | Chief Accounting Officer | 09/01/2026 | Steuer-Abgabe | 19.44 | 1,421 | 27,624 | Form 4 |
| ALKT | Linebarger Douglas A. | Chief Legal Officer | 09/01/2026 | Steuer-Abgabe | 19.44 | 7,381 | 143,487 | Form 4 |
| ALKT | Hudson Cassandra | Chief Financial Officer | 09/01/2026 | Steuer-Abgabe | 19.44 | 8,293 | 161,216 | Form 4 |
| ALKT | Shootman Alex | Chief Executive Officer | 09/01/2026 | Steuer-Abgabe | 19.44 | 5,205 | 101,185 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 09/01/2026 | Verkauf | 46.99 | 9,000 | 422,874 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 09/01/2026 | Optionsausübung | 24.59 | 5,000 | 122,950 | Form 4 |
| ALK | Minicucci Benito | CEO AND PRESIDENT | 08/20/2026 | Kauf | 40.06 | 25,000 | 1,001,510 | Form 4 |
| ALKS | Nichols Christian Todd | SVP, Chief Commercial Officer | 08/17/2026 | Verkauf | 49.65 | 664 | 32,969 | Form 4 |
| ALKS | Nichols Christian Todd | SVP, Chief Commercial Officer | 08/17/2026 | Verkauf | 49.19 | 6,912 | 339,967 | Form 4 |
| ALKT | Hudson Cassandra | Chief Financial Officer | 08/07/2026 | Zuteilung | — | 52,116 | — | Form 4 |
| ALK | Harrison Andrew R | EVP AND CCO | 08/03/2026 | Verkauf | 49.67 | 5,300 | 263,256 | Form 4 |
| ALKS | snyderman nancy lynn MD | Director | 08/03/2026 | Verkauf | 50.35 | 44,472 | 2,239,076 | Form 4 |
| ALKS | snyderman nancy lynn MD | Director | 08/03/2026 | Optionsausübung | 46.72 | 16,524 | 772,001 | Form 4 |
| ALKS | snyderman nancy lynn MD | Director | 08/03/2026 | Optionsausübung | 46.72 | 27,948 | 1,305,731 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 08/03/2026 | Verkauf | 48.58 | 9,000 | 437,220 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 08/03/2026 | Optionsausübung | 24.59 | 4,896 | 120,393 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 08/03/2026 | Optionsausübung | 19.34 | 104 | 2,011 | Form 4 |
| ALKS | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 08/03/2026 | Verkauf | 48.58 | 2,034 | 98,812 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).